IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

BACKGROUND AND OBJECTIVES: Systemic inflammation modulates cardiovascular disease risk and functionality of HDL in the setting of CKD. Whether interventions that modify systemic inflammation can improve HDL function in CKD is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin J Am Soc Nephrol
Asıl Yazarlar: Hung, Adriana M., Tsuchida, Yohei, Nowak, Kristen L., Sarkar, Sudipa, Chonchol, Michel, Whitfield, Victoria, Salas, Natjalie, Dikalova, Anna, Yancey, Patricia G., Huang, Jiansheng, Linton, MacRae F., Ikizler, T. Alp, Kon, Valentina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2019
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500942/
https://ncbi.nlm.nih.gov/pubmed/31015261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04360418
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller